Patent details

EP3470086 Title: PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF

Basic Information

Publication number:
EP3470086
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP181877655
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF
French Title of Invention:
PYRROLOBENZODIAZÉPINES ET LEURS CONJUGUÉS
German Title of Invention:
PYRROLOBENZODIAZEPINE UND KONJUGATE DAVON
SPC Number:

Dates

Filing date:
11/10/2013
Grant date:
25/11/2020
EP Publication Date:
17/04/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/11/2020
EP B1 Publication Date:
25/11/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
11/10/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/11/2020
 
 

Name:
MEDIMMUNE LIMITED
Address:
Milstein Building Granta Park, Cambridge CB21 6GH, United Kingdom (GB)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
11/12/2020
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
Howard, Philip Wilson
Address:
United Kingdom (GB)

Priority

Priority Number:
201261712924 P
Priority Date:
12/10/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61P 35/00; A61P 39/00; C07D 519/00; A61K 47/68;

Publication

European Patent Bulletin

Issue number:
202048
Publication date:
25/11/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
02/11/2026
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
23/09/2025
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
11/12/2020 Power Of Attorney 1
14/12/2020 Outgoing Correspondence 1